|
⚲
|
| Keyboard |
| Brunk Gerald A
✚
|
|
|---|---|
| CIK # | 0001380226 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001380226] | |
| 4 | [0001380226] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| enGene Therapeutics Inc | |
| Brunk Gerald A | |
| Lava Medtech Acquisition Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
|
2025-06-16 | Grant | 22,500 | $0.00 | |
|
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
|
2024-06-15 | Grant | 20,000 | $0.00 | |
|
enGene Therapeutics Inc ENGN
Common Shares
|
2024-02-20 | Grant | 644,965 | $10.00 | 6,449,650 |
|
enGene Therapeutics Inc ENGN
Common Shares
|
2024-02-20 | Grant | 155,035 | $10.00 | 1,550,350 |
|
enGene Therapeutics Inc ENGN
Common Shares
|
2023-10-31 | Grant | 1,341,790 | ||
|
enGene Therapeutics Inc ENGN
Common Shares
|
2023-10-31 | Grant | 83,816 | ||
|
enGene Therapeutics Inc ENGN
Common Shares
|
2023-10-31 | Grant | 348,686 | ||
|
enGene Therapeutics Inc ENGN
Common Shares
|
2023-10-31 | Grant | 44,647 | ||
|
enGene Therapeutics Inc ENGN
Warrants (right to buy) · derivative
|
2023-10-31 | Grant | 114,945 | ||
|
enGene Therapeutics Inc ENGN
Warrants (right to buy) · derivative
|
2023-10-31 | Grant | 145,603 | ||
|
enGene Therapeutics Inc ENGN
Warrants (right to buy) · derivative
|
2023-10-31 | Grant | 9,207 | ||
|
enGene Therapeutics Inc ENGN
Warrants (right to buy) · derivative
|
2023-10-31 | Grant | 38,301 | ||
|
enGene Therapeutics Inc ENGN
Warrants (right to buy) · derivative
|
2023-10-31 | Grant | 3,825 | ||
|
enGene Therapeutics Inc ENGN
Warrants (right to buy) · derivative
|
2023-10-31 | Grant | 20,673 | ||
|
enGene Therapeutics Inc ENGN
Common Shares
|
2023-10-31 | Grant | 1,077,386 | ||
|
enGene Therapeutics Inc ENGN
Common Shares
|
2023-10-31 | Grant | 152,974 |